BEIJING - More than 70 public figures have signed a petition opposing an application for listing on the Shenzhen Stock Exchange submitted by a pharmaceutical company that makes medicine from bear bile. The company, Guizhentang Pharmaceuticals, extracts bile from captive bears to make traditional Chinese medicines. Founded in 2000, the company is among 220 awaiting approval by the Growth Enterprise Board, according to the China Securities Regulatory Commission.

Joel Backaler first traveled to Beijing in 2001. He has held positions in Taiwan, mainland China and Singapore.

We first published details about the APT in our Jan 2010 M-Trends report... Our position was that “The Chinese govt may authorize this activity, but there’s no way to determine the extent of its involvement.” Now, three years later, we have the evidence required to change our assessment. The details we have analyzed during hundreds of investigations convince us that the groups conducting these activities are based primarily in China and that the Chinese Government is aware of them.

the Guardian. A Weekly news paper with the latest news, sport, business, comment, analysis and reviews from the Guardian, the "world's leading liberal voice."

IMF Working Paper: Is China Over-Investing and Does it Matter? Nov, 2012

The deadly threat to civilization from the skies that almost nobody knows about: Strong geomagnetic storm hits Earth, raising worries about power grids http://Sunking278.com

Stratfor's State of the World: Assessing China's Strategy. Long, but very useful

The Official history of US-China relations. A GUIDE TO THE UNITED STATES' HISTORY OF RECOGNITION, DIPLOMATIC, AND CONSULAR RELATIONS, BY COUNTRY, SINCE 1776: CHINA

Carnegie Endowment for International Peace - China section

Pinterest • The world’s catalogue of ideas
Search